Curemark CEO To Receive Springboard Enterprises' Northstar Award for "Visionary Leadership and Breakthrough Research in Autism"

RYE, N.Y., Sept. 29, 2014 /PRNewswire/ -- Curemark, a leading drug research and development company focused on the treatment of neurological and other diseases, is proud to announce that Dr. Joan Fallon, Founder and CEO, will receive Springboard Enterprises' Northstar Award, as recognition for her entrepreneurial leadership and achievements in autism research.  Springboard Enterprises is a non-profit organization dedicated to accelerating high-growth women entrepreneurs' access to equity capital markets. Its 2014 Winners' Circle Dinner will take place at The Boathouse in Central Park in New York on October 21. 

"Dr. Fallon is a visionary scientist who has dedicated her life to helping patients by tailoring treatments that address the root causes of their disorder.  Her groundbreaking work and study of children with autism will lead to meaningful improvements in the lives of children with autism," said Amy Millman, President of Springboard Enterprises.  "We are proud to present Dr. Fallon with the Northstar Award for exemplifying true entrepreneurialism in her unwavering commitment to making her dream of developing a treatment that will help children with autism a reality."

Curemark began with Dr. Fallon's research on the role of gastrointestinal/pancreatic secretory deficiencies in neurological disease.  Critical insights from her clinical observations treating children led to the development of the company's lead product candidate, CM-AT, which has the potential to be a first-in-class treatment for autism and the first therapy to address the core symptoms of the disease.

"I am proud to be recognized by Springboard for this important award," stated Dr. Fallon. "Springboard is an important organization that is dedicated to raising industry support and capital for women-led, high-growth-potential entrepreneurial endeavors focused on the advancement of humanity through breakthrough innovation.  I look forward to collaborating with Springboard in the future in any way that I can to enable more women to realize their dreams."

Springboard entrepreneurs are actively engaged in discovering, investing in and commercializing breakthrough innovations in technology, science and products that make our lives healthier, wealthier and more informed.  These are the innovators with a passion for making the impossible possible.  Northstar honorees epitomize what happens when passion, drive and skill meet opportunity.

About Curemark
Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company previously announced that its Phase III double blind randomized placebo controlled multicenter clinical trial of CM-AT for autism met its primary and secondary endpoints. To learn more about our innovative science, visit www.curemark.com

About Springboard Enterprises
Springboard Enterprises is a highly-vetted expert network of innovators, investors and influencers who are dedicated to building high-growth technology-oriented companies led by women. Our programs and initiatives source, qualify, advise, showcase and support the most promising women-led businesses seeking capital or partnerships for product development and expansion. Springboard companies have raised over $6 billion in financing, have created thousands of jobs and have generated billions in revenue. Learn more about Springboard at their site - https://sb.co/ and follow them on Twitter - @springboardent

MEDIA CONTACT:
Chantal Beaudry, Managing Director
Phone: 646-871-8480
Email:   [email protected]

SOURCE Curemark